Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification
- PMID: 28510807
- DOI: 10.1007/s11547-017-0770-6
Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification
Abstract
Objectives: To evaluate hepatic encephalopathy (HE) incidence after transjugular intrahepatic portosystemic shunt (TIPS) and classify by gravity and frequency.
Methods: This is a retrospective study of 75 patients with no previous episodes of HE who underwent TIPS between 2008 and 2014 with clinical follow-up after 6 and 12 months. Patient risk factors evaluated include age, INR (international normalized ratio), creatinine, bilirubin, and MELD score (Model for End-of-stage Liver Disease). HE was reported using two classifications: (1) gravity divided in moderate (West-Haven grades I-II) and severe (III-IV); (2) frequency divided in episodic and recurrent/persistent.
Results: Overall HE incidence was 36% at 6 months, with 12 month incidence significantly decreased to 27% (p = 0.02). 13/75 (17%) patients had one episode of moderate HE, while 3/75 (4%) patients had severe recurrent/persistent HE. Age was the only pre-TIPS risk predictor. Post-TIPS bilirubin and INR showed variations from basal values only in the presence of diagnosed HE. Bilirubin significantly increased (p = 0.03) in correlation to HE severity, whereas INR changes correlated with temporal frequency (p = 0.04). HE distribution classified for severity is similar at 6 and 12 months, whereas when classified for frequency shows significant differences (p = 0.04).
Conclusions: A classification by gravity and frequency attests post-TIPS HE as a manageable risk. Monitoring of bilirubin and INR may help on clinical management risk stratification.
Keywords: Hepatic encephalopathy; Interventional; Liver; Liver cirrhosis; Portasystemic shunt; Radiology; Transjugular intrahepatic.
Similar articles
-
Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.Hepatobiliary Pancreat Dis Int. 2006 May;5(2):232-6. Hepatobiliary Pancreat Dis Int. 2006. PMID: 16698582
-
Risk Factors for Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in Patients with Hepatocellular Carcinoma and Portal Hypertension.J Gastrointestin Liver Dis. 2015 Sep;24(3):301-7. doi: 10.15403/jgld.2014.1121.243.yao. J Gastrointestin Liver Dis. 2015. PMID: 26405702
-
Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.World J Gastroenterol. 2021 Feb 7;27(5):416-427. doi: 10.3748/wjg.v27.i5.416. World J Gastroenterol. 2021. PMID: 33584073 Free PMC article.
-
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.Acta Gastroenterol Belg. 2023 Apr-Jun;86(2):318-322. doi: 10.51821/86.2.11430. Acta Gastroenterol Belg. 2023. PMID: 37428165 Review.
-
Interventional Radiology Management of Hepatic Encephalopathy.Clin Liver Dis. 2024 May;28(2):317-329. doi: 10.1016/j.cld.2024.01.008. Epub 2024 Feb 10. Clin Liver Dis. 2024. PMID: 38548442 Review.
Cited by
-
Drainage of ascites in cirrhosis.World J Hepatol. 2024 Sep 27;16(9):1245-1257. doi: 10.4254/wjh.v16.i9.1245. World J Hepatol. 2024. PMID: 39351514 Free PMC article. Review.
-
Predicting overt hepatic encephalopathy after TIPS: Value of three minimal hepatic encephalopathy tests.JHEP Rep. 2023 Jun 28;5(9):100829. doi: 10.1016/j.jhepr.2023.100829. eCollection 2023 Sep. JHEP Rep. 2023. PMID: 37600959 Free PMC article.
-
Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges.J Clin Med. 2020 Nov 23;9(11):3784. doi: 10.3390/jcm9113784. J Clin Med. 2020. PMID: 33238576 Free PMC article. Review.
-
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088. World J Gastroenterol. 2019. PMID: 30862997 Free PMC article.
-
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial).BMJ Open Gastroenterol. 2020 Dec;7(1):e000531. doi: 10.1136/bmjgast-2020-000531. BMJ Open Gastroenterol. 2020. PMID: 33372103 Free PMC article. Clinical Trial.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical